Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Other financing activities (2016 - 2025)

Historic Other financing activities for Apyx Medical (APYX) over the last 11 years, with Q2 2025 value amounting to $30000.0.

  • Apyx Medical's Other financing activities changed N/A to $30000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $71000.0, marking a year-over-year decrease of 9474.85%. This contributed to the annual value of $11000.0 for FY2024, which is 9964.58% down from last year.
  • According to the latest figures from Q2 2025, Apyx Medical's Other financing activities is $30000.0.
  • Apyx Medical's Other financing activities' 5-year high stood at $1.8 million during Q1 2023, with a 5-year trough of $11000.0 in Q4 2024.
  • Over the past 3 years, Apyx Medical's median Other financing activities value was $30000.0 (recorded in 2025), while the average stood at $635400.0.
  • Over the last 5 years, Apyx Medical's Other financing activities had its largest YoY gain of 9918.64% in 2024, and its largest YoY loss of 9918.64% in 2024.
  • Apyx Medical's Other financing activities (Quarter) stood at $1.4 million in 2023, then crashed by 99.19% to $11000.0 in 2024, then skyrocketed by 172.73% to $30000.0 in 2025.
  • Its Other financing activities stands at $30000.0 for Q2 2025, versus $30000.0 for Q1 2025 and $11000.0 for Q4 2024.